Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 29Leucovorin 26Oxaliplatin 25Capecitabine 16Irinotecan 14Cetuximab 10Bevacizumab 9Radiotherapy 8Panitumumab 5Folfox protocol 5Surgical Procedures, Operative 3Levamisole 3Celecoxib 3tremelimumab 2neratinib 2napabucasin 2durvalumab 2cediranib 2aflibercept 2X-Rays 2Tegafur 2Radiofrequency Ablation 2Psychiatric Rehabilitation 2Preoperative Exercise 2Octreotide 2Mitomycin 2Interviews as Topic 2Immunoglobulin G 2Folic Acid 2Floxuridine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Colorectal Neoplasms × Immunoenzyme Techniques × Clear all
NCT00897754 2017-05-19

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Eastern Cooperative Oncology Group

Completed
200 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡